MedPath

青海晨菲制药有限公司

Ownership
-
Established
2006-12-27
Employees
-
Market Cap
-
Website
www.qhcfzy.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

25

NMPA:25

Drug Approvals

Nitroglycerin Injection

Product Name
硝酸甘油注射液
Approval Number
国药准字H20254311
Approval Date
May 27, 2025
NMPA

Nitroglycerin Injection

Product Name
硝酸甘油注射液
Approval Number
国药准字H20254310
Approval Date
May 27, 2025
NMPA

Peramivir Injection

Product Name
帕拉米韦注射液
Approval Number
国药准字H20243854
Approval Date
May 28, 2024
NMPA

Nicergoline for Injection

Product Name
注射用尼麦角林
Approval Number
国药准字H20084198
Approval Date
Aug 11, 2023
NMPA

Nicergoline for Injection

Product Name
注射用尼麦角林
Approval Number
国药准字H20084197
Approval Date
Aug 11, 2023
NMPA

Nicergoline for Injection

Product Name
注射用尼麦角林
Approval Number
国药准字H20084199
Approval Date
Aug 11, 2023
NMPA

Exenatide Injection

Product Name
艾塞那肽注射液
Approval Number
国药准字H20223543
Approval Date
Jul 29, 2022
NMPA

Exenatide Injection

Product Name
艾塞那肽注射液
Approval Number
国药准字H20223542
Approval Date
Jul 29, 2022
NMPA

Ozagrel Sodium for Injection

Product Name
注射用奥扎格雷钠
Approval Number
国药准字H20084146
Approval Date
Aug 5, 2020
NMPA

Omeprazole Sodium for Injection

Product Name
注射用奥美拉唑钠
Approval Number
国药准字H20046035
Approval Date
Aug 5, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.